By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PerkinElmer, Inc. 

940 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-663-6900 Fax:


SEARCH JOBS
PerkinElmer, Inc. is a global technology leader providing scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets that require innovation, precision and reliability. We design, manufacture, market and service products and systems within three business units: Life and Analytical Sciences, Optoelectronics and Fluid Sciences.

Facts about PerkinElmer

  • 2003 Revenue $1.535 Billion
  • Operating in 125 countries
  • 10,000 employees
  • Member S&P 500 Index

    PerkinElmer Life and Analytical Sciences

    549 Albany Street
    Boston, MA 02118, USA
    Telephone General Information 617-482-9595 or Customer Care 800-762-4000 (USA only)
    Email ProductInfo@perkinelmer.com

    A $1 billion market leader, PerkinElmer LAS serves a number of growing industries and markets including the academic research, biotechnology, clinical screening, pharmaceutical, environmental, forensic, petrochemical and semiconductor segments. Our instruments, reagents, consumables and service offerings help our customers solve complex analytical problems encountered in drug discovery and genetic screening laboratories. Our instruments and related software applications measure a range of substances from biomolecular matter to organic and inorganic materials. Our total application-driven laboratory solutions help our customers speed drug discovery, enhance research productivity, meet strict regulatory requirements, improve time-to-market, and increase manufacturing efficiencies.

    Last Updated: 12-14-04

    Key Statistics


    Email: productinfo@perkinelmer.com
    Ownership: Public

    Web Site: PerkinElmer
    Employees:
    Symbol: PKI
     



  • Industry
    Suppliers






    Company News
    PerkinElmer (PKI) To Hold Earnings Call On Thursday, August 3, 2017 7/11/2017 7:24:39 AM
    PerkinElmer (PKI) Release: Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate Of Pre-Term Preeclampsia 6/28/2017 11:07:45 AM
    PerkinElmer (PKI) Slams Down $1.3 Billion for Germany's EUROIMMUN 6/19/2017 5:44:14 AM
    Mobidiag Extends Distribution Agreement With PerkinElmer (PKI) To Offer Amplidiag Diagnostics Products In African Countries And Israel 5/30/2017 6:49:01 AM
    PerkinElmer (PKI) Announces Financial Results For The First Quarter Of 2017 5/5/2017 6:28:53 AM
    PerkinElmer (PKI) Completes Sale Of Medical Imaging Business To Varex Imaging (VREX) 5/2/2017 6:29:14 AM
    PerkinElmer (PKI) Board Declares Quarterly Dividend 5/1/2017 6:52:27 AM
    PerkinElmer (PKI) To Hold Earnings Call On Thursday, May 4, 2017 4/10/2017 6:39:28 AM
    PerkinElmer (PKI) Release: Phase I Clinical Trial Examines Safety Of Using Cord Blood Stem Cells For Treating Children With Autism Spectrum Disorder 4/5/2017 7:38:26 AM
    New Cloud-Based PerkinElmer (PKI) Signals Notebook Helps Scientists Accelerate Drug Discovery Research 4/3/2017 8:27:10 AM
    12345678910...
    //-->